FOXO
FOXO TECHNOLOGIES INC.
- PER (TTM)
- -
- PER (Forward)
- -
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 0.02
- 시가총액
- 373,266
- 배당수익률
- -
- 베타
- 2.35
- 1개월 수익률
- 0.00%
- 3개월 수익률
- 100.00%
- 6개월 수익률
- -93.33%
- 1년 수익률
- -99.99%
- 2년 수익률
- -
- 5일 평균거래량
- 1115193
- 60일 평균거래량
- 13581016
- 1년 평균거래량
- 25490965
- 5d/60d 거래량 비율
- 0.08×
- 60d/1y 거래량 비율
- 0.53×
- 변동성(60일, 연환산)
- 379.74%
- BB 스퀴즈 스코어
- 0.00
- SMA50 비율
- 1.01
- SMA200 비율
- 0.01
- RSI (14)
- 50
- 20일 수렴도
- 0.00
- 52주 최고
- 1.45
- 52주 최저
- 0.00
- 고점 대비
- -99.99%
- 저점 대비
- 100.00%
펀더멘털 갱신: 2026-05-10T09:01:51+00:00 · 시세 갱신: 2026-05-10T06:34:49+00:00
회사 정보
FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. The company operates through two segments: Healthcare and Labs and Life. The company offers behavioural health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; and other services. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in West Palm Beach, Florida.